CEO Seunghoon Choi buys 3,149 common shares in open market... stake rises to 0.77%


  • CEO Seunghoon Choi purchased 3,149 common shares on May 26, 2026 at 6,649 won per share via open market, increasing his stake from 0.69% to 0.77% (up 0.08%p).
  • The purchase amount is approximately 20.9 million won, representing only 0.08% of total outstanding shares, a minor transaction.
  • While insider buying is often viewed as a positive signal of management confidence, the small scale of this purchase limits its impact on the stock price in the near term.
  • [AI Comprehensive Analysis]This disclosure is merely a small open market purchase by the CEO and does not materially affect the company’s intrinsic value or shareholder value. Investors should consider other factors for investment decisions.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Daesung Microbiological Labs (036480)
  • Submission: Seunghoon Choi
  • Receipt: 05-26-2026